The “2012 Cardiac Cath Lab Performance Survey” includes responses from 359 cath lab leaders and staff members, 90 percent of whom represent hospital-based labs with the remaining 10 percent representing private practice and Veterans Affairs/government facilities.
Respondents listed the following core services as a percent of overall revenue:
• Diagnostic health catheterization — 37.7 percent
• Percutaneous coronary intervention — 19.4 percent
• Implants (PPG, implantable cardioverter defibrillator, biventricular) — 15.3 percent
• Diagnostic peripherals — 8.1 percent
• Electrophysiology (mapping, ablation, EP studies) — 7.8 percent
• Interventional peripherals — 7.5 percent
• Other (transesophageal echocardiography, tilt table testing, cardioversions) — 4.2 percent
Respondents also reported their 2012 capital expenditures:
• Imaging equipment — 38.7 percent
• Cardiovascular information systems — 23.4 percent
• Hemodynamics — 21 percent
• Ablation equipment — 17.7 percent
• All of the above — 8.1 percent
• None of the above — 24.2 percent
More Articles on Hospital Cardiology:
The Cardiovascular Service Line Approach: Creating Value in Organization Structure
Report: Nearly 45% of Cath Lab Staff Say Volume Was Biggest Challenge in 2011
Study: Regional Coordination of Heart Attack Patients Improves Survival
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
